Sector consensus Indivior PLC London S.E.

Equities

Market Closed - London S.E. Other stock markets 11:35:04 2025-07-24 EDT			5-day change	1st Jan Change
1,238.00 ^GBX	+1.56%		-.--%	-

01-08	Indivior PLC Provides Earnings Guidance for the Full Year 2026	CI
01-08	Indivior Expects Up to $1.20 Billion in 2026 Net Revenue	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
MERCK KGAA			€150.63	+15.87%	16
KYOWA KIRIN CO., LTD.			JP¥2,635	+2.65%	10
HALOZYME THERAPEUTICS, INC.			US$77.13	+8.31%	8
SK BIOPHARMACEUTICALS CO., LTD.			₩145,571.43	+20.91%	14
YUHAN CORPORATION			₩148,555.56	+37.68%	18
BETTA PHARMACEUTICALS CO., LTD.			CN¥63.79	+28.14%	2
SUPERNUS PHARMACEUTICALS, INC.			US$61.33	+22.67%	6
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	-	-	-	-	-
KISSEI PHARMACEUTICAL CO., LTD.			JP¥5,000	+5.82%	5
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-	-	CN¥32	+58.89%	1
Average			33,571.87	+22.32%	9
Weighted average by Cap.			17,375.25	+16.56%	14